Comment on

• Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients.

  Bhalla A, Pultz NJ, Ray AJ, Hoyen CK, Eckstein EC, Donskey CJ. Bhalla A, et al. Infect Control Hosp Epidemiol. 2003 Sep;24(9):644-9. doi: 10.1086/502267. Infect Control Hosp Epidemiol. 2003. PMID: 14510245
• Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance.

  Bernard L, Vaudaux P, Vuagnat A, Stern R, Rohner P, Pittet D, Schrenzel J, Hoffmeyer P; Osteomyelitis Study Group. Bernard L, et al. Infect Control Hosp Epidemiol. 2003 Sep;24(9):650-4. doi: 10.1086/502268. Infect Control Hosp Epidemiol. 2003. PMID: 14510246 Clinical Trial.
• Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance.

  Lodise TP Jr, McKinnon PS, Rybak M. Lodise TP Jr, et al. Infect Control Hosp Epidemiol. 2003 Sep;24(9):655-61. doi: 10.1086/502269. Infect Control Hosp Epidemiol. 2003. PMID: 14510247
• Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants.

  Cordero L, Ayers LW. Cordero L, et al. Infect Control Hosp Epidemiol. 2003 Sep;24(9):662-6. doi: 10.1086/502270. Infect Control Hosp Epidemiol. 2003. PMID: 14510248